MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Screening for Genetic Forms in Non-focal Dystonia Patients in Russian Population.

    L. Zaripova, A. Protopopova, N. Abramycheva, E. Fedotova, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To assess clinical spectrum of genetic forms of dystonia (GD) in a cohort of Russian patients with non-focal dystonia. Background: Dystonia is the third…
  • 2025 International Congress

    Multiplex Proteomic Analysis of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathophysiology and Progression

    L. Higginbotham, A. Shantaraman, Q. Guo, E. Fox, P. Bagchi, F. Wu, J. Lah, A. Levey, N. Seyfried (Altanta, USA)

    Objective: To evaluate the performance of a multiplexed proteomic assay in a large multi-center Lewy Body dementia (LBD) cohort. Background: LBD, which comprises Parkinson’s disease…
  • 2025 International Congress

    Plasma proteomic profiles and risk of Parkinson’s disease: a prospective study from UK Biobank

    C. Li, B. Ke, X. Zheng, Y. Xiao, S. Wang, Q. Jiang, J. Lin, J. Huang, H. Shang (Chengdu, China)

    Objective: To identify proteins associated with risk of Parkinson's disease (PD). Background: Alterations in plasma protein levels manifest early in individuals at risk of PD.…
  • 2025 International Congress

    Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

    A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)

    Objective: To integrate [18F]-FDG PET (fPET) and objective motor performance to unravel metabolic networks associated with deep brain stimulation (DBS) outcomes in Parkinson’s disease (PD).…
  • 2025 International Congress

    Autoimmune GFAP astrocytopathy as an Etiology of Opsoclonus-Myoclonus-Ataxia Syndrome

    T. Thammongkolchai, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a case of opsoclonus-myoclonus-ataxia syndrome (OMAS) due to autoimmune GFAP astrocytopathy. Background: OMAS is associated with brainstem pathology. In adults, common causes…
  • 2025 International Congress

    Unraveling the Estrogen-Parkinson’s Disease Link: Methodological Challenges in Meta-Analyzing Reproductive Factors and PD Risk.

    EP. Papathoma, TN. Ntetsika, TS. Soumala, IM. Markaki (Solna, Sweden)

    Objective: To address key methodological challenges in the methodology of meta-analysis of age at menopause, reproductive lifespan and the risk of Parkinson’s Disease (PD). Background:…
  • 2025 International Congress

    Blood levels of Cathepsin B are linked to a reduced risk of Parkinson’s disease

    X. Guo, R. Li (Xi'an, China)

    Objective: To assess the causal impact of plasma Cathepsin B (CTSB) levels on Parkinson’s disease (PD) risk. Background: Cathepsin B is a crucial lysosomal cysteine…
  • 2025 International Congress

    Associations between Inflammation and Sleep Quality in Parkinson’s Disease: Exploring the Potential Influence of Sex.

    J. Cristini, V. Daneault, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, L. Rodrigues, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)

    Objective: To investigate associations between inflammatory blood markers and sleep quality in Parkinson’s Disease (PD) and explore whether biological sex influences these associations. Background: Inflammation…
  • 2025 International Congress

    Neurite Orientation Dispersion and Density Imaging revals reveals white matter microstructural changes in isolated REM sleep behavior disorder

    E. Mak, S. Przybelski, R. Reid, A. Fought, C. Schwarz, P. Vemuri, C. Jack JR., Y. Nie, H. Delacruz, A. Avidan, D. Bliwise, M. Campbell, S. Criswell, A. Davis, K. Duff, K. Ehgoetz Martens, J. Elliot, T. Ferman, J. Fields, L. Forsberg, J. Gagnon, Z. Gan-Or, M. Howell, M. Hu, X. Hu, D. Huddleston, P. Kotzbauer, J. Langley, M. Lim, J. Locke, V. Lowe, S. Mccarter, J. Mcleland, M. Miglis, E. Mignot, T. Miyagawa, L. Neilson, K. Nichols, A. Pelletier, O. Ross, C. Schenck, S. Wolfgang, E. ST. Louis, L. Trotti, A. Videnovic, C. Xiong, R. Postuma, Y. Ju, B. Boeve, K. Kantarci (Rochester, USA)

    Objective: To characterize white matter microstructural alterations in isolated REM sleep behavior disorder (iRBD) using both conventional diffusion tensor imaging and advanced Neurite Orientation Dispersion…
  • 2025 International Congress

    Chronic Exercise and Systemic Inflammation in Parkinson’s Disease: Exploring the Role of Exercise Modality

    J. Cristini, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)

    Objective: To investigate the effects of 12 weeks of cardiovascular, resistance, multimodal training, or a waiting list condition on the concentrations of inflammatory blood markers…
  • « Previous Page
  • 1
  • …
  • 368
  • 369
  • 370
  • 371
  • 372
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley